Statera Biopharma Inc.

---

Innovative companies credit collaboration with success

 March 19, 2024 2:48:17 pm

---

Statera Biopharma explores merger with California life-sciences firm

 March 21, 2023 1:49:28 pm

---

Statera Biopharma reports $101M loss for 2021 fiscal year

 October 7, 2022 2:02:03 pm

---

Statera Biopharma set for Nasdaq delisting hearing

 September 27, 2022 2:28:50 pm

---

Statera Biopharma faces involuntary bankruptcy petition

 September 9, 2022 12:45:02 pm

---

Statera hires new accounting firm

 June 16, 2022 2:38:51 pm

---

Registration for SPAC led by Statera CEO declared abandoned

 May 26, 2022 8:44:04 pm

---

Statera Biopharma faces Nasdaq delisting as violations pile up

 May 24, 2022 8:54:54 pm

---

Statera Biopharma sells rights to addiction-treatment drug, still faces delisting from Nasdaq

 May 4, 2022 8:37:26 pm

---

Statera Biopharma dropped by accounting firm

 April 18, 2022 8:57:55 pm

Next Page »